Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in thousands)
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Sales | -22 | 18 | 39 | 40 | 48 |
| Cost of Goods | -17 | 17 | 12 | 94 | 25 |
| Gross Profit | -5 | 0 | 26 | -54 | 23 |
| Operating Expenses | 520 | 499 | 574 | 896 | 826 |
| Operating Income | -525 | -499 | -547 | -951 | -802 |
| Interest Expense | 162 | 240 | 214 | 211 | 107 |
| Other Income | 274 | -292 | 294 | -283 | 491 |
| Pre-tax Income | -413 | -1,031 | -468 | -1,444 | -418 |
| Net Income Continuous | -413 | -1,031 | -468 | -1,444 | -418 |
| Net Income | $-413 | $-1,031 | $-468 | $-1,444 | $-418 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.01 | -0.04 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.03 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.01 | -0.04 | -0.01 |
| EBITDA(a) | $-160 | $-619 | $-115 | $-1,045 | $-202 |